Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Search by expertise, name or affiliation
Treatment of chronic lymphocytic leukemia
Jan A. Burger
Leukemia
Research output
:
Contribution to journal
›
Review article
›
peer-review
183
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of chronic lymphocytic leukemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chronic Lymphocytic Leukemia
100%
Chronic Lymphocytic Leukemia Cells
60%
B-cell Receptor Signaling
60%
B-cell Lymphoma 2 (Bcl-2)
40%
Leukemia Therapy
40%
Chemotherapy
20%
High Risk
20%
Survival Benefit
20%
Combination Therapy
20%
Therapeutic Target
20%
Anti-apoptotic
20%
Drug Resistance
20%
Clinical Trials
20%
Treatment Strategy
20%
Lymph Node
20%
Low Risk
20%
Spleen
20%
B Lymphocytes
20%
Phosphatidylinositol 3-kinase Inhibitor
20%
Kinase Inhibitor
20%
High Cost
20%
Bruton's Tyrosine Kinase
20%
Tissue Microenvironment
20%
Ibrutinib
20%
Bruton Tyrosine Kinase Inhibitor
20%
Molecular Targeted Agents
20%
Secondary Lymphoid Organs
20%
Anti-CD20
20%
Intermittent Preventive Treatment
20%
Isoform Selectivity
20%
Deep Remission
20%
New Targeted Drugs
20%
Fixation Duration
20%
Venetoclax
20%
Acalabrutinib
20%
Medicine and Dentistry
B-Cell Chronic Lymphocytic Leukemia
100%
Leukemia Cell
37%
B Lymphocyte Receptor
37%
B-Cell Lymphoma
25%
Health Care Cost
12%
Combination Therapy
12%
Side Effect
12%
Lymph Node
12%
Clinical Trial
12%
Chemotherapy
12%
Drug Resistance
12%
Phosphoinositide 3-Kinase Inhibitor
12%
Antiapoptotic
12%
B Lymphocyte
12%
Phosphotransferase Inhibitor
12%
Bruton Tyrosine Kinase
12%
Ibrutinib
12%
Bruton Tyrosine Kinase Inhibitor
12%
CD20 Antibody
12%
Lymphoid Organ
12%
Venetoclax
12%
Acalabrutinib
12%